These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8901009)

  • 1. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.
    Halonen T; Nissinen J; Jansen JA; Pitkänen A
    Eur J Pharmacol; 1996 Mar; 299(1-3):69-81. PubMed ID: 8901009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine.
    Walton NY; Gunawan S; Treiman DM
    Epilepsy Res; 1994 Dec; 19(3):237-44. PubMed ID: 7698100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat.
    Halonen T; Nissinen J; Pitkänen A
    Epilepsy Res; 2001 Sep; 46(3):205-23. PubMed ID: 11518623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat.
    Halonen T; Nissinen J; Pitkänen A
    Epilepsy Res; 1999 Apr; 34(2-3):251-69. PubMed ID: 10210040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.
    Suzdak PD; Jansen JA
    Epilepsia; 1995 Jun; 36(6):612-26. PubMed ID: 7555976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
    Kälviäinen R
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala.
    Pitkänen A; Tuunanen J; Halonen T
    Epilepsy Res; 1996 May; 24(1):29-45. PubMed ID: 8800633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats.
    Halonen T; Nissinen J; Pitkänen A
    Neuropharmacology; 2001 Mar; 40(4):536-50. PubMed ID: 11249963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria.
    Piccinelli P; Borgatti R; Perucca E; Tofani A; Donati G; Balottin U
    Epilepsia; 2000 Nov; 41(11):1485-8. PubMed ID: 11077464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of tolerance to the anticonvulsant effects of tiagabine following chronic (21 day) treatment.
    Suzdak PD
    Epilepsy Res; 1994 Dec; 19(3):205-13. PubMed ID: 7698096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vigabatrin treatment on status epilepticus-induced neuronal damage and mossy fiber sprouting in the rat hippocampus.
    Pitkänen A; Nissinen J; Jolkkonen E; Tuunanen J; Halonen T
    Epilepsy Res; 1999 Jan; 33(1):67-85. PubMed ID: 10022367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
    Smith SE; Parvez NS; Chapman AG; Meldrum BS
    Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship.
    Cleton A; Altorf BA; Voskuyl RA; Danhof M
    Eur J Pharm Sci; 2000 Dec; 12(2):141-50. PubMed ID: 11102742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment.
    Skodda S; Kramer I; Spittler JF; Gehlen W
    J Neurol; 2001 Feb; 248(2):109-12. PubMed ID: 11284127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling.
    Haas KZ; Sperber EF; Opanashuk LA; Stanton PK; Moshé SL
    Hippocampus; 2001; 11(6):615-25. PubMed ID: 11811655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levetiracetam on visual-spatial memory following status epilepticus.
    Zhou JL; Zhao Q; Holmes GL
    Epilepsy Res; 2007 Jan; 73(1):65-74. PubMed ID: 17029741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H
    Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of carbamazepine to prevent behavioural and histopathological sequels of experimentally induced status epilepticus.
    Lahtinen H; Ylinen A; Lukkarinen U; Sirviö J; Miettinen R; Riekkinen P
    Eur J Pharmacol; 1996 Feb; 297(3):213-8. PubMed ID: 8666052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unaltered control of extracellular GABA-concentration through GAT-1 in the hippocampus of rats after pilocarpine-induced status epilepticus.
    Frahm C; Stief F; Zuschratter W; Draguhn A
    Epilepsy Res; 2003 Jan; 52(3):243-52. PubMed ID: 12536057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.